Meeder Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Meeder Advisory Services’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.07M	Buy	1,896 +25	+1%	+$16K	0.04%	265
2025 Q4	$1.27M	Buy	1,871 +102	+6%	+$69.5K	0.05%	231
2025 Q3	$1.13M	Buy	1,769 +244	+16%	+$148K	0.05%	244
2025 Q2	$818K	Buy	1,525 +42	+3%	+$20.1K	0.04%	293
2025 Q1	$623K	Sell	1,483 -89	-6%	-$38.6K	0.04%	317
2024 Q4	$650K	Sell	1,572 -377	-19%	-$165K	0.04%	302
2024 Q3	$985K	Sell	1,949 -180	-8%	-$87.4K	0.06%	243
2024 Q2	$1.04M	Buy	2,129 +540	+34%	+$271K	0.07%	216
2024 Q1	$858K	Buy	1,589 +66	+4%	+$36.1K	0.09%	198
2023 Q4	$845K	Buy	1,523 +38	+3%	+$17.8K	0.1%	182
2023 Q3	$649K	Sell	1,485 -222	-13%	-$111K	0.08%	211
2023 Q2	$857K	Sell	1,707 -3	-0.2%	-$1.44K	0.09%	190
2023 Q1	$855K	Buy	1,710 +219	+15%	+$105K	0.1%	178
2022 Q4	$608K	Buy	+1,491	New	+$579K	0.08%	234

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Meeder Advisory Services's IDXX Position: Q1 2026 in Review

Meeder Advisory Services increased its Idexx Laboratories (IDXX) stake by 1.3% in Q1 2026, buying an estimated $16K and bringing the position to 1,896 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #265.

Meeder Advisory Services first reported a position in IDXX in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.27M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Meeder Advisory Services held 1,896 shares of Idexx Laboratories worth $1.07M as of Q1 2026.
Meeder Advisory Services bought 25 Idexx Laboratories shares in Q1 2026, an estimated $16K.
Idexx Laboratories made up 0.04% of Meeder Advisory Services's portfolio in Q1 2026, its #265 holding.
Meeder Advisory Services first reported a position in Idexx Laboratories in Q4 2022 and has held it in 14 quarters since.
Meeder Advisory Services's Idexx Laboratories position peaked at $1.27M in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.